Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
about
Liver x receptor signaling pathways and atherosclerosis.Liver X receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 expression.Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.Inflammation, lipid metabolism dysfunction, and hypertension: active research fields in atherosclerosis-related cardiovascular disease in China.Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.
P2860
Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Liver X receptor agonist T0901 ...... up-regulating NPC1 expression.
@en
type
label
Liver X receptor agonist T0901 ...... up-regulating NPC1 expression.
@en
prefLabel
Liver X receptor agonist T0901 ...... up-regulating NPC1 expression.
@en
P2093
P2860
P1476
Liver X receptor agonist T0901 ...... up-regulating NPC1 expression.
@en
P2093
ChaoKe Tang
DongLi Cao
XiaoYan Dai
XinRui Hao
YaLing Tang
ZhiFeng Long
P2860
P2888
P304
P356
10.1007/S11427-008-0054-4
P577
2008-05-01T00:00:00Z
P6179
1031547610